EBioMedicine (Jan 2016)

Small CD4 Mimetics Prevent HIV-1 Uninfected Bystander CD4+ T Cell Killing Mediated by Antibody-dependent Cell-mediated Cytotoxicity

  • Jonathan Richard,
  • Maxime Veillette,
  • Shilei Ding,
  • Daria Zoubchenok,
  • Nirmin Alsahafi,
  • Mathieu Coutu,
  • Nathalie Brassard,
  • Jongwoo Park,
  • Joel R. Courter,
  • Bruno Melillo,
  • Amos B. Smith III,
  • George M. Shaw,
  • Beatrice H. Hahn,
  • Joseph Sodroski,
  • Daniel E. Kaufmann,
  • Andrés Finzi

DOI
https://doi.org/10.1016/j.ebiom.2015.12.004
Journal volume & issue
Vol. 3, no. C
pp. 122 – 134

Abstract

Read online

Human immunodeficiency virus type 1 (HIV-1) infection causes a progressive depletion of CD4+ T cells. Despite its importance for HIV-1 pathogenesis, the precise mechanisms underlying CD4+ T-cell depletion remain incompletely understood. Here we make the surprising observation that antibody-dependent cell-mediated cytotoxicity (ADCC) mediates the death of uninfected bystander CD4+ T cells in cultures of HIV-1-infected cells. While HIV-1-infected cells are protected from ADCC by the action of the viral Vpu and Nef proteins, uninfected bystander CD4+T cells bind gp120 shed from productively infected cells and are efficiently recognized by ADCC-mediating antibodies. Thus, gp120 shedding represents a viral mechanism to divert ADCC responses towards uninfected bystander CD4+ T cells. Importantly, CD4-mimetic molecules redirect ADCC responses from uninfected bystander cells to HIV-1-infected cells; therefore, CD4-mimetic compounds might have therapeutic utility in new strategies aimed at specifically eliminating HIV-1-infected cells.

Keywords